Disease Info Card

Liver Dysfunction

Information about Liver Dysfunction: characteristics, related genes and pathways, plus antibodies you can use for research. This page is being enriched constantly, if you see some information you would like this page to include please send your suggestions to us.

Overview of Liver Dysfunction

Most recent studies have shown that Liver Dysfunction shares some biological mechanisms with anemia, carcinoma, cholestasis, drug-induced-liver-injury, fibrosis, hemorrhage, hepatitis, hepatitis-b, hepatitis-c, hypertensive-disease, icterus, liver-carcinoma, liver-cirrhosis, liver-damage, liver-diseases, liver-failure, liver-neoplasms, malignant-neoplasms, neoplasms, pain.

Among the many pathways, these few ones have gauged particular interests from scientists studying Liver Dysfunction, and have been seen in publications frequently: Aging, Blood Coagulation, Cell Death, Coagulation, Excretion, Fatty Acid Oxidation, Fibrinolysis, Glomerular Filtration, Gluconeogenesis, Hemostasis, Hypersensitivity, Immune Response, Inflammatory Response, Liver Regeneration, Pathogenesis, Pigmentation, Regeneration, Secretion, Transport, Urea Cycle

Quite a number of genes have been found to play important roles in Liver Dysfunction, such as AFP, ALB, ALPP, ASRGL1, ATRNL1, BCHE, CRP, DPAGT1, F2, FAM126A, GGT1, GGT2, GPT, IL6, INS, SLC17A5, SLPI, TNF. See what Boster has to offer for the research of these genes by clicking the gene name links below and view a more detailed info card/product listing for that gene.

In a later update, we will include information such as current drugs and therapy solutions as well as on-going and past clinical trials for this disease. Plesae stay updated.